Lennox G, Lowe J, Landon M, Byrne E J, Mayer R J, Godwin-Austen R B
Department of Neurology, Queen's Medical Centre, Nottingham, United Kingdom.
J Neurol Neurosurg Psychiatry. 1989 Nov;52(11):1236-47. doi: 10.1136/jnnp.52.11.1236.
Diffuse Lewy body disease is an important pathological substrate of the common syndrome of parkinsonian dementia. The new technique of anti-ubiquitin immunocytochemistry has been used in a correlative quantitative neuropathological study of fifteen cases of diffuse Lewy body disease, showing that the severity of dementia is related to cortical Lewy body density, whilst subcortical abnormalities make a much less significant contribution. Cortical senile plaques also appear to be part of the pathology of diffuse Lewy body disease and should not therefore be used as an isolated diagnostic criterion for Alzheimer's disease. Diagnostic criteria for diffuse Lewy body disease are discussed.
弥漫性路易体病是帕金森病痴呆常见综合征的重要病理基础。抗泛素免疫细胞化学新技术已用于15例弥漫性路易体病的相关定量神经病理学研究,结果表明痴呆的严重程度与皮质路易体密度有关,而皮质下异常的影响则小得多。皮质老年斑似乎也是弥漫性路易体病病理的一部分,因此不应将其作为阿尔茨海默病的独立诊断标准。本文讨论了弥漫性路易体病的诊断标准。